Chevy Chase Trust Holdings Inc. cut its position in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 3.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 739,517 shares of the pharmacy operator’s stock after selling 27,048 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.07% of Walgreens Boots Alliance worth $59,620,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of WBA. Jolley Asset Management LLC increased its position in shares of Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 700 shares during the last quarter. Westbourne Investment Advisors Inc. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $121,000. Cribstone Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $149,000. MU Investments Co. Ltd. bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $150,000. Finally, Signaturefd LLC increased its position in shares of Walgreens Boots Alliance by 2.7% in the second quarter. Signaturefd LLC now owns 1,802 shares of the pharmacy operator’s stock worth $150,000 after buying an additional 48 shares during the last quarter. Institutional investors and hedge funds own 60.36% of the company’s stock.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.86% during trading on Friday, hitting $83.27. 5,013,338 shares of the stock traded hands. The company has a market capitalization of $90.20 billion, a P/E ratio of 21.80 and a beta of 1.19. The company’s 50 day moving average is $80.77 and its 200 day moving average is $80.94. Walgreens Boots Alliance Inc. has a one year low of $71.50 and a one year high of $87.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.08. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The business had revenue of $28.60 billion for the quarter, compared to analysts’ expectations of $29.06 billion. During the same period in the prior year, the firm earned $0.88 earnings per share. Walgreens Boots Alliance’s revenue was up .4% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance Inc. will post $5.01 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Thursday, November 17th will be paid a dividend of $0.375 per share. The ex-dividend date of this dividend is Tuesday, November 15th. This represents a $1.50 annualized dividend and a dividend yield of 1.80%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 39.27%.

A number of brokerages have commented on WBA. Jefferies Group set a $95.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Sunday, October 23rd. Credit Suisse Group AG reiterated an “outperform” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Friday, October 21st. Deutsche Bank AG reiterated a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, November 10th. Barclays PLC set a $79.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Friday, October 21st. Finally, Leerink Swann set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, November 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $90.30.

In related news, Director William C. Foote sold 2,067 shares of the stock in a transaction that occurred on Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total value of $168,047.10. Following the transaction, the director now directly owns 24,623 shares in the company, valued at $2,001,849.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $85.00, for a total transaction of $2,039,660.00. The disclosure for this sale can be found here. Insiders own 21.10% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.